Dexmedetomidine is an a2-adrenergic receptor agonist with an eight-fold greater affinity for the a2-adrenergic receptor than its sister drug clonidine. It is a sedative that is clear, colourless and tasteless and has been used in children for a number of years. Advantages of Dexmedetomidine over other agents used in paediatrics include: ease of administration; reduction in postoperative analgesic requirements; and reduction in postoperative nausea and vomiting (PONV).
- Cyclophilin D Contributes to Anesthesia Neurotoxicity in the Developing Brain
- Evaluation of the Toxicity of Sugammadex in Zebrafish Larvae
- Potential Neurodevelopmental Effects of Pediatric Intensive Care Sedation and Analgesia: Repetitive Benzodiazepine and Opioid Exposure Alters Expression of Glial and Synaptic Proteins in Juvenile Rats
- Sevoflurane inhibits neuronal migration and axon growth in the developing mouse cerebral cortex
- Iron overload contributes to general anaesthesia-induced neurotoxicity and cognitive deficits